Related Experiment Video
Updated: Jun 23, 2026

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
Microbicide product development
1Population Council, New York, New York 10065, USA. rmaguire@popcouncil.org
Purpose Of Review:
The purpose of this overview is to summarize the essential parameters needed to establish a sound microbicide development strategy.
Recent Findings:
In recent years more comprehensive regulatory guidelines that are applicable to microbicides have been developed. Additionally, the US Food and Drug Administration have begun providing specific guidance for microbicide development.
Summary:
Microbicide product development has been aided in recent years by new regulatory guidance that helps to establish a stepwise development strategy. Developing comprehensive profiles for three key criteria - quality, safety and efficacy - are essential for preparation of an investigational new drug application that will allow proceeding into clinical development to establish microbicide proof-of-concept.
Insights
Establishing a successful microbicide development strategy requires understanding key parameters. Recent regulatory guidance aids in creating comprehensive quality, safety, and efficacy profiles for clinical trials.
Area of Science:
- Pharmaceutical Sciences
- Infectious Diseases
- Regulatory Science
Background:
- Microbicides are crucial for preventing sexually transmitted infections.
- Developing effective microbicides faces regulatory and scientific challenges.
- Recent advancements in regulatory science have impacted microbicide development.
Purpose of the Study:
- To outline essential parameters for a robust microbicide development strategy.
- To highlight the role of regulatory guidance in microbicide product development.
- To define the critical components for advancing microbicides into clinical trials.
Main Methods:
- Review of current regulatory guidelines for microbicide development.
- Analysis of essential data requirements for investigational new drug applications.
- Synthesis of key quality, safety, and efficacy parameters.
Main Results:
- Comprehensive regulatory guidelines for microbicides are now available.
- The US Food and Drug Administration (FDA) provides specific development guidance.
- Stepwise development strategies are facilitated by new regulatory frameworks.
Conclusions:
- New regulatory guidance supports a structured approach to microbicide development.
- Establishing thorough quality, safety, and efficacy profiles is vital.
- These profiles are essential for investigational new drug applications and clinical proof-of-concept studies.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Automated Microbial Diagnostics
Microbial Corrosion
Chemical Agents for Microbial Control
Clinical Significance of Antibiotic Resistance

